Skip to Main Content

Paper Details

Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age.
American Journal of Epidemiology
22
2021
Women, breast cancer, colorectal cancer, coronary heart disease, endometrial cancer, equine, estrogens, heart disease, hip fracture, hysterectomy, invasive breast cancer, medroxyprogesterone acetate, participants, progestin, pulmonary embolism, stroke, women

Datasets

Release 1.2